Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF

Journal of Comparative Neurology

Volumn 515, Issue 1, 2009, Pages 31-40

  Redmond Jr , D Eugene ^a   Elsworth, J D ^a   Roth, R H ^a   Leranth, C ^a   Collier, T J ^b   Blanchard, B ^c   Bjugstad, K B ^c   Samulski, R J ^d   Aebischer, P ^e   Sladek Jr , J R ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Children's Hospital Colorado   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e EPFL   (Switzerland)

Author keywords

Dopaminergic neurons; FG; Neurite extension; Parkinsonian non human primate

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAUDATE NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; GENE DELIVERY SYSTEM; GENE OVEREXPRESSION; MALE; MESENCEPHALON; MONKEY; NERVE CELL GROWTH; NERVE GRAFT; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; GROWTH CONES; MALE; NEURAL PATHWAYS; NEURITES; PARKINSONIAN DISORDERS; STAINING AND LABELING; STEM CELL TRANSPLANTATION; STILBAMIDINES; SUBSTANTIA NIGRA; TREATMENT OUTCOME; UP-REGULATION;

EID: 67650901996     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22028     Document Type: Conference Paper

References (38)

1. Barroso-Chinea P, Cruz-Muros I, Aymerich MS, Rodriguez-Diaz M, Afonso-Oramas D, Lanciego JL, Gonzalez-Hernandez T. 2005. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. Eur J Neurosci 21:1815-1827.
2. Bentlage C, Nikkhah G, Cunningham MG, Bjorklund A. 1999. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp Neurol 159:177-190.
3. Bjorklund A, Dunnett SB. 2007. Fifty years of dopamine research. Trends Neurosci 30:185-187.
4. Brecknell JE, Du JS, Muir E, Fidler PS, Hlavin ML, Dunnett SB, Fawcett JW. 1996a. Bridge grafts of fibroblast growth factor-4-secreting schwannoma cells promote functional axonal regeneration in the nigrostriatal pathway of the adult rat. Neuroscience 74:775-784.
5. Brecknell JE, Haque NS, Du JS, Muir EM, Fidler PS, Hlavin ML, Fawcett JW, Dunnett SB. 1996b. Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat. Neuroscience 71:913-925.
6. Choi-Lundberg DL, Bohn MC. 1995. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res Dev Brain Res 85:80-88.
7. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. 1997. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838-841.
8. Collier TJ, Sortwell CE, Elsworth JD, Taylor JR, Roth RH, Sladek JR Jr, Redmond DE, Jr. 2002. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J Comp Neurol 442:320-330.
9. Deglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D, Aebischer P. 2000. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 11:179-190.
10. Dowd E, Monville C, Torres EM, Wong LF, Azzouz M, Mazarakis ND, Dunnett SB. 2005. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur J Neurosci 22):2587-2595.
11. Elsworth JD, Redmond DE Jr, Leranth C, Bjugstad KB, Sladek JR Jr, Collier TJ, Foti SB, Samulski RJ, Vives KP, Roth RH. 2008. AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons. Exp Neurol 211:252-258.
12. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA. 1996. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255.
13. Hovland DN Jr, Boyd RB, Butt MT, Engelhardt JA, Moxness MS, Ma MH, Emery MG, Ernst NB, Reed RP, Zeller JR, Gash DM, Masterman DM, Potter BM, Cosenza ME, Lightfoot RM. 2007. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol Pathol 35:676-692.
14. Jimenez-Castellanos J, Graybiel AM. 1987. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23:223-242.
15. Jimenez-Castellanos J, Graybiel AM. 1989. Evidence that histochemically distinct zones of the primate substantia nigra pars compacta are related to patterned distributions of nigrostriatal projection neurons and striatonigral fibers. Exp Brain Res Exp Hirnforsch 74:227-238.
16. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
17. Kordower JH, Herzog CD, Dass B, Bakay RA, Stansell J 3rd, Gasmi M, Bartus RT. 2006. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Ann Neurol 60:706-715.
18. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. 2008. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506.
19. Langer LF, Jimenez-Castellanos J, Graybiel AM. 1991. The substantia nigra and its relations with the striatum in the monkey. Prog Brain Res 87:81-99.
20. Leichtle SW, Zufferey R, Bober J, Leranth C, Markakis EA, Samulski RJ, Zhou X, Aebischer P, Vives KP, Redmond DE, Jr. 2009. AAV2 is superior to EIAV vector for long-term expression of human GDNF in the African green monkey nigrostriatal system. Hum Gene Ther. in revision.
21. Leranth C, Sladek JR Jr, Roth RH, Redmond DE, Jr. 1998. Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals. Exp Brain Res Exp Hirnforsch 123:323-333.
22. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P. 2008. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14:501-503.
23. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
24. Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, Breeze R, Fahn S, Freed C, Eidelberg D. 2002. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 52:628-634.
25. Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT. 2008. Safety and tolerability of intraputaminal delivery of CERE-120 (adenoassociated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol 7:400-408.
26. Mendez I, Hong M. 1997. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using Fluoro-Gold and horseradish peroxidase. Brain Res 778:194-205.
27. Mendez I, Sadi D, Hong M. 1996. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16:7216-7227.
28. Mendez I, Baker KA, Hong M. 2000. Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease. Brain Res Brain Res Rev 32:328-339.
29. Mendez I, Dagher A, Hong M, Gaudet P, Weerasinghe S, McAlister V, King D, Desrosiers J, Darvesh S, Acorn T, Robertson H. 2002. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 96:589-596.
30. Mendez I, Vinuela A, Astradsson A, Mukhida K, Hallett P, Robertson H, Tierney T, Holness R, Dagher A, Trojanowski JQ, Isacson O. 2008. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 14:507-509.
31. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ. 2002. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76:791-801.
32. Redmond DE Jr. 2002. Cellular replacement therapy for Parkinson's disease-where are we today? Neuroscientist 8:457-488.
33. Redmond DE Jr, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, Sladek JR, Jr., Sidman RL, Snyder EY. 2007. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A 104:12175-12180.
34. Sladek JR Jr, Bjugstad KB, Collier TJ, Bundock EA, Blanchard BC, Elsworth JD, Roth RH, Redmond DE, Jr. 2008. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate. Cell Transplant 17:427- 444.
35. Sladek JR Jr, Elsworth JD, Taylor JR, Roth RH, Redmond DE Jr. 1995. Techniques for neural transplantation in non-human primates. C. Ricordi, editor. Methods in Cell Transplantation. Austin, TX: R.G. Landes. p 391-408.
36. Stromberg I, Bjorklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C. 1993. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401-412.
37. Tang FI, Tien LT, Zhou FC, Hoffer BJ, Wang Y. 1998. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Exp Brain Res Exp Hirnforsch 119: 287-296.
38. Tatarewicz SM, Wei X, Gupta S, Masterman D, Swanson SJ, Moxness MS. 2007. Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion. J Clin Immunol 27:620-627.